CompletedNot Applicable

Stromal Vascular Fraction (SVF) Injection in the Treatment of Patellar Tendinopathy

Italy30 participantsStarted 2021-07-01

Plain-language summary

The aim of the study is the evaluation of clinical and radiological results after the treatment of patellar tendinopathy through the injection of autologous ultrasound-guided, intra- and peri-tendon stromal vascular fraction.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Ultrasound or MRI signs of patellar tendon pathology Exclusion Criteria: * BMI \> 30 * Patients suffering from: rheumatic diseases, diabetes, infectious processes, epilepsy, severe osteoporosis * Patients undergoing intra-tendon infiltration of another substance within the previous 6 months; * Patients who had patellar tendon surgery within the previous 12 months; * Immunodepression * On going systemic inflammatory diseases (stabilized outcomes of such diseases are not considered absolute contraindications).

What they're measuring

Victorian Institute of Sport Assessment-Patella (VISA-P) questionnaire

Timeframe: 6 months

Trial details

NCT IDNCT04753853

SponsorIstituto Ortopedico Rizzoli

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-02-10

View on ClinicalTrials.gov More Patellar Tendinitis trials